Radionecrosis risk and local control after CyberKnife® fractionated stereotactic radiotherapy for brain metastases: an eight-year single-centre cohort

Abstract Background Stereotactic radiotherapy (SRT) is an effective treatment for patients with a limited number of brain metastases (BM). However, radionecrosis (RN) remains a concern, particularly in long-term survivors, as its distinction from tumor progression is challenging and may lead to inap...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Aurélia Alati, Philippe Giraud, Jean‑Emmanuel Bibault, Emmanuelle Fabiano, Sarah Kreps, Catherine Durdux
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-03-01
Rangatū:	Radiation Oncology
Ngā marau:	Stereotactic radiotherapy Brain metastases Fractionated stereotactic radiotherapy Radionecrosis Radiation necrosis Radiosurgery
Urunga tuihono:	https://doi.org/10.1186/s13014-026-02824-x
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!